Jeffrey Stokes, M.D.

Profile picture
Professor of Pediatrics, Division of Allergy Immunology and Pulmonary Medicine
Allergy and Pulmonary Medicine

phone: (314) 454-2694

Clinical Interests

Dr. Stokes is a Professor of Pediatrics at Washington University School of Medicine. Dr. Stokes did his early training at the University of Kansas Medical Center with his subsequent fellowships in Pediatric Pulmonary Medicine and Allergy/Immunology at the University of Wisconsin in Madison. He is board certified in Pediatrics, Pediatric Pulmonary Medicine, and Allergy and Clinical Immunology. After completing his training he was in private practice in Omaha, Nebraska for 3 years. Dr. Stokes then joined Creighton University School of Medicine where he was faculty for 14 years. Dr. Stokes primary clinic responsibility in Omaha was to care for the Military members and their families from the Offutt Air Force base. He was the Allergy/Immunology Fellowship Program Director for 12 years. He joined the faculty at Washington University in St. Louis the summer of 2016. His clinical and research interests include childhood asthma and the development of allergic diseases. Dr. Stokes looks forward to treating the children of the St. Louis area and their families.


  • BS, (cum laude) Pre-Med/Life Sciences, Kansas State University1987
  • MD, University of Kansas Medical Center1991


  • Resident, Pediatrics, University of Kansas Medical Center1991 - 1994
  • Fellow, Pediatric Pulmonology, University of Wisconsin Hospitals & Clinics1994 - 1997
  • Fellow, Allergy & Immunology, University of Wisconsin Hospitals & Clinics1997 - 1998

Licensure and Board Certification

  • 1992National Board of Medical Examiners
  • 1994American Board of Pediatrics. Recertified 2000, 2008
  • 1998American Board of Pediatric Pulmonology-Subspecialty. Recertified 2005, 2015
  • 1998 - 2016Medical License, State of Nebraska
  • 1999American Board of Allergy and Immunology. Recertified 2009, 2019
  • 2005 - 2016Medical License, State of Iowa
  • 2016 - PresMedical License, State of Missouri
  • 2018 - PresMedical License, State of Illinois

Honors and Awards

  • Hospitality Award-Ehrling Bergquist Hospital2003
  • American College of Allergy, Asthma and Immunology: Clinical Fellowship Stipend Award2006 - 2008
  • Best Doctors® in America2011 - Pres

Recent Publications view all (37)

Publication Co-Authors

  1. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet. 2022;400(10351):502-511. PMID:35964610 
  2. Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation. Contemp Clin Trials. 2021;100:106228. PMCID:PMC7887056  PMID:33242697 
  3. Prevention and treatment of recurrent viral-induced wheezing in the preschool child. Ann Allergy Asthma Immunol. 2020;125(2):156-162. PMID:32454096 
  4. Eosinophilic Asthma. J Allergy Clin Immunol Pract. 2020;8(2):465-473. PMID:31786254 
  5. Anti-IgE Treatment for Disorders Other Than Asthma. Front Med (Lausanne). 2017;4:152. PMCID:PMC5613080  PMID:28983485 
  6. Characterization of asthma endotypes: implications for therapy. Ann Allergy Asthma Immunol. 2016;117(2):121-5. PMID:27499539 
  7. The use of anti-IgE therapy beyond allergic asthma. J Allergy Clin Immunol Pract. 2015;3(2):162-6. PMID:25609342 
  8. Promising future therapies for asthma. Int Immunopharmacol. 2014;23(1):373-7. PMID:24957689 
  9. Immunotherapy: what lies beyond. J Allergy Clin Immunol. 2014;133(3):612-9: quiz 620. PMID:24581428 
  10. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms. J Allergy Clin Immunol. 2012;129(2):409-12, 412.e1-2. PMID:22196768 
  11. Allergic rhinitis and asthma: celebrating 100 years of immunotherapy. Curr Opin Immunol. 2011;23(6):808-13. PMID:21862303 
  12. Future forms of immunotherapy and immunomodulators in allergic disease. Immunol Allergy Clin North Am. 2011;31(2):343-65, x-xi. PMID:21530824 
  13. Future forms of immunotherapy. J Allergy Clin Immunol. 2011;127(1):8-15; quiz 16-7. PMID:21094518 
  14. Immunomodulators in asthma therapy. Curr Allergy Asthma Rep. 2009;9(6):475-83. PMID:19814921 
  15. Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma. Ann Allergy Asthma Immunol. 2009;103(1):31-7. PMID:19663124 
  16. Limitations of objective measures of asthma. Ann Allergy Asthma Immunol. 2009;102(6):530-1. PMID:19558014 
  17. Utility and limitations of objective measures of asthma. Ann Allergy Asthma Immunol. 2009;102(6):518-22. PMID:19558012 
  18. Anti-IgE therapy: clinical utility beyond asthma. J Allergy Clin Immunol. 2009;123(4):770-1.e1. PMID:19348915 
  19. The natural history of methacholine responsivenesss in the CAMP study: who becomes unresponsive? Am J Respir Crit Care Med. 2009;179(7):622; author reply 622-3. PMID:19318544 
  20. Asthma and obesity. Ann Allergy Asthma Immunol. 2008;101(6):641-3. PMID:19119710 
  21. Dyspnea and obesity in African American women. Ann Allergy Asthma Immunol. 2008;101(6):644-5. PMID:19119711 
  22. Anti-immunoglobulin e therapy. World Allergy Organ J. 2008;1(10):174-83. PMCID:PMC3651047  PMID:23282676 
  23. Immunomodulators for allergic respiratory disorders. J Allergy Clin Immunol. 2008;121(2):288-96; quiz 297-8. PMID:18269921 
  24. Allergy immunotherapy: indications, efficacy, and safety. J Respir Dis. 2008;29:136-141. 
  25. Intranasal corticosteroids for the treatment of perennial allergic rhinitis. Southern Med J. 2007;100:667-668. 
  26. Allergy immunotherapy for primary care physicians. Am J Med. 2006;119(10):820-3. PMID:17000208 
  27. Managing impairment in patients with allergic rhinitis. Allergy Asthma Proc. 2006;27(1):12-6. PMID:16598987 
  28. Managing impairment in patients with allergic rhinitis. Allergy Asthma Proc. 2006;27:12-16. 
  29. Pediatric allergic rhinitis: treatment. Immunol Allergy Clin North Am. 2005;25(2):283-99, vi. PMID:15878456 
  30. Ragweed skin test responsiveness correlates with specific immunoglobulin E levels. Allergy Asthma Proc. 2005;26(2):103-7. PMID:15971467 
  31. Management of the patient with allergic asthma. Resident and Staff Physician. 2005;51:23-40. 
  32. Rationale for new treatments aimed at IgE immunomodulation. Ann Allergy Asthma Immunol. 2004;93(3):212-7; quiz 217-9, 271. PMID:15478378 
  33. Cannabis (hemp) positive skin tests and respiratory symptoms. Ann Allergy Asthma Immunol. 2000;85(3):238-40. PMID:11030280 
  34. Attenuation of virus-induced airway dysfunction in rats treated with imiquimod. Eur Respir J. 1998;11(2):324-9. PMID:9551732 
  35. Antileukotriene therapy in asthma. Semin Respir Crit Care Med. 1998;19(6):647-656. 
  36. The bridging bronchus. Successful diagnosis and repair. Arch Otolaryngol Head Neck Surg. 1997;123(12):1344-7. PMID:9413366 
  37. Ragweed skin test responsiveness correlates with specific immunoglobulin E levels. Allergy and Asthma Proc. 26(2):103-107. 
Last updated: 10/08/2022
© 2022 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130